Tag: India
Mayo Clinic opens patient information office in India
Mayo Clinic accepts appointment requests directly from patients and patient referrals from physicians
Budget 2023: Agri industry positive about digital initiatives, accelerator fund
This budget will promote R&D, innovation, and digitization of agriculture apart from promoting disruption through the startup ecosystem
Budget 2023: Healthcare industry welcomes focus on skill development & PPP
An increase in budget allocation for health infrastructure and digital transformation will enable a futuristic development of the country’s health bodies
Marengo Asia Hospitals partners Werfen to bring unique transfusion free heart...
The Marengo Asia-Werfen partnership will play a crucial role in the development of “Centre of Excellence”
Budget 2023: Biotech industry leaders hail fresh initiatives
The focus on R&D initiatives via creation of Centres of Excellence and opening up ICMR labs for private companies has earned praise from the industry stakeholders
Budget 2023: Healthcare industry experts find ‘Misses’ are more dominating than...
However, the sector is optimistic that with a pragmatic budget provision, the government would certainly consider the long-pending demands of the sector before finalizing the Budget.
Dr Soumya Swaminathan takes charge of M S Swaminathan Research Foundation
I look forward to working with the staff of MSSRF and rural, tribal and coastal communities to use science for sustainable development,” Dr Soumya Swaminathan said in a statement
Budget 2023: Industry leaders appreciate key takeways, focus on digitalization &...
Check out the post budget 2023 reactions from bioscience industry stakeholders
Dr Mansukh Mandaviya unveils FSSAI’s calendar to celebrate International Year of...
FSSAI to formulate guidelines for schools, hospitals and government canteens to incorporate millets as nutritional menu
Vaccines with efficacy against Omicron variants will gain competitive advantage in...
According to GlobalData’s Pharma Intelligence Center, there are currently 19 COVID-19 vaccines in clinical development in China, with only 3 candidates in Phase III trials